[artículo] 
inJournal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 6 (Diciembre) . - pp. 561-568

Título :	The double-blind variable placebo lead-in period: results from two antidepressant clinical trials
Tipo de documento:	texto impreso
Autores:	Douglas E. Faries, Autor ; John H. Heiligenstein, Autor ; Gary D. Tollefson, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 561-568
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antidepresivos, Ensayos clínicos, Trastorno depresivo mayor, Ensayos controlados aleatorios
Resumen:	The 1-week single-blind placebo lead-in has long been a standard in double-blind psychopharmacology clinical trials. Although a lead-in period is often necessary (e.g., to receive laboratory results before randomization), some authors have demonstrated that the standard single-blind placebo lead-in’s performance was similar to having a lead-in in which placebo was not administered.
Link:	./index.php?lvl=notice_display&id=31101

[artículo] The double-blind variable placebo lead-in period: results from two antidepressant clinical trials [texto impreso] / Douglas E. Faries, Autor ; John H. Heiligenstein, Autor ; Gary D. Tollefson, Autor . - 2023 . - pp. 561-568.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 6 (Diciembre) . - pp. 561-568

Palabras clave:	Antidepresivos, Ensayos clínicos, Trastorno depresivo mayor, Ensayos controlados aleatorios
Resumen:	The 1-week single-blind placebo lead-in has long been a standard in double-blind psychopharmacology clinical trials. Although a lead-in period is often necessary (e.g., to receive laboratory results before randomization), some authors have demonstrated that the standard single-blind placebo lead-in’s performance was similar to having a lead-in in which placebo was not administered.
Link:	./index.php?lvl=notice_display&id=31101